Bio-Rad Laboratories, Inc.BIO
NYSE•Healthcare•Medical Devices
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $2.59B, growing 1.9% year-over-year. TTM net income stood at $168.80M (107.8% growth). Quarterly EBITDA was $34.10M and operating income was $34.10M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze BIO growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters